EarningsQ2 2026 Earnings Report
MX:CTVA Q2 2026 EPS Results
Actual EPS$40.79
Consensus EPS$39.66
Beat/MissBeat by +$1.14
One Year Ago EPS$39.02
MX:CTVA Q2 2026 Revenue Results
Actual Revenue$113.14B
Expected Revenue$117.05B
Beat/MissMissed by -$3.91B
YoY Revenue Growth-1.19%
Earnings Announcement Details
QuarterQ2 2026
Date07/30/2026
TimeAfter Close
Conference CallThursday, July 30, 2026
MX:CTVA Upcoming Earnings
Corteva's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:CTVA Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.Company Guidance
Raised Full-Year Guidance
Operating EBITDA guidance increased to $4.1B–$4.3B and operating EPS to $3.60–$3.80. At the midpoint this implies ~9% EBITDA growth and ~11% EPS growth versus prior year.
First Half Revenue and EBITDA Growth
First half net sales rose 4% to $11.3B (organic sales +2%). First half operating EBITDA increased 10% to $3.7B, driven by strong commercial execution across seed and crop protection.
Margin Expansion and EPS
Operating margins expanded (nearly 200 bps of margin improvement referenced; margin reported at 32.8% in the first half). Operating EPS increased 14% in the first half.
Strong Seed Performance and Licensing Momentum
Organic seed sales improved across all regions (led by North America and EMEA). Net royalties improved by ~$90M and the licensing business is several years ahead of plan, with licensing contributing materially to pricing/mix.
Crop Protection New-Product Momentum
New crop protection products are a growing engine (~$2B of revenue expected this year from new products) with volumes up (high single-digit growth in new products) and pricing essentially flat in the first half for new introductions.
Productivity, Cost and Currency Benefits
Cost and productivity improvements contributed >$160M to EBITDA; price & mix added ~ $100M; volume contributed ~ $40M; currency contributed ~ $85M — collectively driving ~ $350M year-over-year EBITDA improvement in H1.
Separation Progress and Lower-than-Expected Dis-synergies
Separation (targeting Oct 1) on track with Form 10 filed, leadership and boards appointed, investor day planned. Run-rate dis-synergies largely offset; timing-related headwind this year reduced to ~ $25M (better than earlier estimates).
Long-Term R&D and Capital Returns
Since 2019 the company invested nearly $9B in R&D, improved operating EBITDA by $1.7B and expanded margins by ~750 bps, while returning nearly $8B of cash to shareholders — supporting long-term value creation.
MX:CTVA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed